Puma Biotechnology Inc - Asset Resilience Ratio

Latest as of December 2025: 31.39%

Puma Biotechnology Inc (PBYI) has an Asset Resilience Ratio of 31.39% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$67.90 Million

Cash + Short-term Investments

Total Assets

$216.30 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how Puma Biotechnology Inc's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Puma Biotechnology Inc to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Puma Biotechnology Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PBYI market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$67.90 Million	31.39%
Total Liquid Assets	$67.90 Million	31.39%

Asset Resilience Insights

Very High Liquidity: Puma Biotechnology Inc maintains exceptional liquid asset reserves at 31.39% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Puma Biotechnology Inc Industry Peers by Asset Resilience Ratio

Compare Puma Biotechnology Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Samsung Biologics Co Ltd KO:207940	Biotechnology	5.66%
Revolution Medicines Inc NASDAQ:RVMD	Biotechnology	65.10%
Abivax SA PA:ABVX	Biotechnology	2.34%
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	Biotechnology	5.07%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	43.36%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%
REMEGEN CO. LTD YC 1 F:REG	Biotechnology	16.77%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Annual Asset Resilience Ratio for Puma Biotechnology Inc (2011–2025)

The table below shows the annual Asset Resilience Ratio data for Puma Biotechnology Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	31.39%	$67.89 Million	$216.30 Million	+16.51pp
2024-12-31	14.88%	$31.75 Million	$213.33 Million	+9.96pp
2023-12-31	4.93%	$11.35 Million	$230.53 Million	+2.73pp
2022-12-31	2.19%	$4.87 Million	$222.06 Million	-6.18pp
2021-12-31	8.37%	$18.98 Million	$226.59 Million	+5.06pp
2020-12-31	3.32%	$8.10 Million	$244.22 Million	-18.65pp
2019-12-31	21.97%	$51.61 Million	$234.91 Million	-0.03pp
2018-12-31	22.00%	$57.00 Million	$259.12 Million	--
2017-12-31	0.00%	$0.00	$165.53 Million	--
2016-12-31	13.85%	$35.00 Million	$252.79 Million	-63.00pp
2015-12-31	76.84%	$184.30 Million	$239.84 Million	+13.68pp
2014-12-31	63.16%	$102.80 Million	$162.76 Million	+23.97pp
2013-12-31	39.19%	$40.90 Million	$104.37 Million	--
2012-12-31	0.00%	$0.00	$151.70 Million	--
2011-12-31	0.00%	$0.00	$55.40 Million	--

pp = percentage points

About Puma Biotechnology Inc

NASDAQ:PBYI USA Biotechnology

Market Cap

$422.27 Million

Market Cap Rank

#13420 Global

#3282 in USA

Share Price

$8.30

Change (1 day)

-2.70%

52-Week Range

$3.07 - $8.53

All Time High

$132.45